Low protein diets in patients with chronic kidney disease: a bridge between mainstream and complementary-alternative medicines?

BMC Nephrology

Volumn 17, Issue 1, 2016, Pages 1-13

  Piccoli, Giorgina Barbara ^a,b   Capizzi, Irene ^a,b   Vigotti, Federica Neve ^a,b   Leone, Filomena ^c   D'Alessandro, Claudia ^d   Giuffrida, Domenica ^c   Nazha, Marta ^a,b   Roggero, Simona ^a,b   Colombi, Nicoletta ^c   Mauro, Giuseppe ^c   Castelluccia, Natascia ^c   Cupisti, Adamasco ^d   Avagnina, Paolo ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b Centre Hospitaler le Mans   (France)

^c UNIVERSITY OF TURIN   (Italy)

^d UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATIVE MEDICINE; CHRONIC KIDNEY DISEASE; CLINICAL EFFECTIVENESS; DIET SUPPLEMENTATION; DISEASE COURSE; END STAGE RENAL DISEASE; EVIDENCE BASED MEDICINE; FOLLOW UP; FOOD SAFETY; GLOMERULUS FILTRATION RATE; HOLISTIC CARE; HUMAN; LIFESTYLE MODIFICATION; MALNUTRITION; OMNIVORE; PATIENT COUNSELING; PATIENT EDUCATION; PERSONALIZED MEDICINE; PROTEIN INTAKE; PROTEIN RESTRICTION; REVIEW; TIME TO TREATMENT; TREATMENT OUTCOME; UREMIA; VEGAN DIET; VEGETARIAN DIET; CHRONIC KIDNEY FAILURE; DIET THERAPY; DIRECTIVE COUNSELING; HEALTHY LIFESTYLE; HEMODIALYSIS; KIDNEY TRANSPLANTATION; PROCEDURES;

COMPLEMENTARY THERAPIES; DIET, PROTEIN-RESTRICTED; DIET, VEGAN; DIRECTIVE COUNSELING; HEALTHY LIFESTYLE; HUMANS; KIDNEY TRANSPLANTATION; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC;

EID: 84992124456     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/s12882-016-0275-x     Document Type: Review

References (204)

1. Eknoyan G. Artificial kidneys: progress and promise. Lancet. 2007;370:1977-8.
2. Sinnakirouchenan R, Holley JL. Peritoneal dialysis versus hemodialysis: risks, benefits, and access issues. Adv Chronic Kidney Dis. 2011;18:428-32.
3. Remuzzi G, Benigni A, Finkelstein FO, et al. Kidney failure: aims for the next 10 years and barriers to success. Lancet. 2013;3(82):353-62.
4. Zoorob R, Chakrabarty S, O'Hara H, Kihlberg C. Which CAM modalities are worth considering? J Fam Pract. 2014;63:585-90.
5. Snyder J, Brown P. Complementary and alternative medicine in children: an analysis of the recent literature. Curr Opin Pediatr. 2012;24:539-46.
6. Huebner J, Marienfeld S, Abbenhardt C, et al. Counseling patients on cancer diets: a review of the literature and recommendations for clinical practice. Anticancer Res. 2014;34:39-48.
7. Zander ME, Wargovich MJ, Hebert JR. Methodologic considerations in the study of diet as part of complementary and alternative medicine modalities. Altern Ther Health Med. 2004;10:56-61.
8. Lewis DS. On the Influence of a Diet with High Protein Content on the Kidney. Can Med Assoc J. 1921;11:682-3.
9. Addis T, Lew W. Diet and death in acute uremia. J Clin Invest. 1939;18:773-5.
10. Addis T. Glomerular nephritis: Diagnosis and treatment. London, UK: Macmillan; 1949.
11. Piccoli GB. Patient-based continuum of care in nephrology: why read Thomas Addis' "Glomerular Nephritis" in 2010? J Nephrol. 2010;23:164-7.
12. Borst JG. Protein katabolism in uraemia; effects of protein-free diet, infections, and blood-transfusions. Lancet. 1948;1:824-9.
13. Giovannetti S, Maggiore Q. A low-nitrogen diet with proteins of high biological value for severe chronic uraemia. Lancet. 1964;1:1000-3.
14. Kerr ND, Robson A, Ashcroft R. Diet in chronic renal failure. Proc R Soc Med. 1967;60:115-6.
15. Berlyne GM, Janabi KM, Shaw AB. Dietary treatment of chronic renal failure. Proc R Soc Med. 1966;59:665-7.
16. Wright PL, Brereton PJ, Snell DEM. Effectiveness of modified Giovannetti diet compared with mixed low-protein diet. Metabolism. 1970;19:201-13.
17. Hood CEA, Beale DJ, Housley J, Hardwicke J. Dialysed egg as nitrogen source in dietray control of chronic renal failure. Lancet. 1969;293:479-82.
18. Franklin SS, Gordon A, Kleeman CR, Maxwell MH. Use of a balanced low-protein diet in chronic renal failure. JAMA. 1967;202:477-84.
19. Berlyne GM, Gaan D, Ginks WR. Dietary treatment of chronic renal failure. Am J Clin Nutr. 1968;21:547-52.
20. Mitch WE, Remuzzi G. Diets for patients with chronic kidney disease, still worth prescribing. J Am Soc Nephrol. 2004;15:234-7.
21. Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, Saran R, Wang AY, Yang CW. Chronic kidney disease: global dimension and perspectives. Lancet. 2013;382:260-72.
22. Bergstrom J. Discovery and rediscovery of low protein diet. Clin Nephrol. 1984;21:29-35.
23. Walser M, Mitch WE, Maroni BJ, Kopple JD. Should protein intake be restricted in predialysis patients? Kidney Int. 1999;55:771-7.
24. Piccoli GB, Ferraresi M, Deagostini MC, et al. Vegetarian low-protein diets supplemented with keto analogues: a niche for the few or an option for many? Nephrol Dial Transplant. 2013;28:2295-305.
25. Foundation NK. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 Suppl 1):S1-266.
26. Eckardt KU, Berns JS, Rocco MV, Kasiske BL. Definition and classification of CKD: the debate should be about patient prognosis--a position statement from KDOQI and KDIGO. Am J Kidney Dis. 2009;53:915-20.
27. López-Novoa JM, Rodríguez-Peña AB, Ortiz A, Martínez-Salgado C, López Hernández FJ. Etiopathology of chronic tubular, glomerular and renovascular nephropathies: clinical implications. J Transl Med. 2011;9:13-30.
28. Burns A, Carson R. Maximum conservative management: a worthwhile treatment for elderly patients with renal failure who choose not to undergo dialysis. J Palliat Med. 2007;10:1245-7.
29. Murtagh FE, Sheerin NS, Addington-Hall J, Higginson IJ. Trajectories of illness in stage 5 chronic kidney disease: a longitudinal study of patient symptoms and concerns in the last year of life. Clin J Am Soc Nephrol. 2011;6:1580-90.
30. O'Hare AM, Batten A, Burrows NR, et al. Trajectories of kidney function decline in the 2 years before initiation of long-term dialysis. Am J Kidney Dis. 2012;59:513-22.
31. Peralta CA, Vittinghoff E, Bansal N, et al. Trajectories of kidney function decline in young black and white adults with preserved GFR: results from the Coronary Artery Risk Development in Young Adults (CARDIA) study. Am J Kidney Dis. 2013;62:261-6.
32. Li L, Chang A, Rostand SG, et al. A within-patient analysis for time-varying risk factors of CKD progression. J Am Soc Nephrol. 2014;25:606-13.
33. Li L, Astor BC, Lewis J, et al. Longitudinal progression trajectory of GFR among patients with CKD. Am J Kidney Dis. 2012;59:504-12.
34. Levey AS, Inker LA, Matsushita K, et al. GFR decline as an end point for clinical trials in CKD: a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration. Am J Kidney Dis. 2014;64:821-35.
35. Lambers Heerspink HJ, Tighiouart H, et al. GFR decline and subsequent risk of established kidney outcomes: a meta-analysis of 37 randomized controlled trials. Am J Kidney Dis. 2014;64:860-6.
36. Greene T, Teng CC, Inker LA, et al. Utility and validity of estimated GFR-based surrogate time-to-event end points in CKD: a simulation study. Am J Kidney Dis. 2014;64:867-79.
37. Hostetter TH, Olson JL, Rennke HG, Venkatachalam MA, Brenner BM. Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am J Physiol. 1981;241:F85-93.
38. Brenner BM. Nephron adaptation to renal injury or ablation. Am J Physiol. 1985;249(3 Pt 2):F324-37.
39. Klahr S, Levey AS, Beck GJ, et al. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med. 1994;330:877-84.
40. Levey AS, Greene T, Beck GJ, Caggiula AW, Kusek JW, Hunsicker LG, Klahr S. Dietary protein restriction and the progression of chronic renal disease: What have all of the results of the MDRD study shown? J Am Soc Nephrol. 1999;10:2426-39.
41. Kopple JD, Greene T, Chumlea WC, et al. Relationship between nutritional status and the glomerular filtration rate: results from the MDRD study. Kidney Int. 2000;57:1688-703.
42. Viberti G, Bognetti E, Wiseman MJ, Dodds R, Gross JL, Keen H. Effect of protein-restricted diet on renal response to a meat meal in humans. Am J Physiol. 1987;253(3 Pt 2):F388-93.
43. Bernhard J, Beaufrere B, Laville M, Fouque D. Adaptive response to a low-protein diet in predialysis chronic renal failure patients. J Am Soc Nephrol. 2001;12(6):1249-54.
44. Nesrallah GE, Mustafa RA, Clark WF, et al. Canadian Society of Nephrology 2014 clinical practice guideline for timing the initiation of chronic dialysis. CMAJ. 2014;186(2):112-7.
45. el Nahas AM, Coles GA. Dietary treatment of chronic renal failure: ten unanswered questions. Lancet. 1986;1:597-600.
46. Fouque D, Laville M. Low protein diets for chronic kidney disease in non diabetic adults. Cochrane Database Syst Rev. 2009;(3).
47. Fouque D, Mitch WE. Low-protein diets in chronic kidney disease: are we finally reaching a consensus? Nephrol Dial Transplant. 2015;30:6-8.
48. Mennini F, Russo S, Marcellusi A, Quintaliani G, Fouque D. Economic effects of treatment of chronic kidney disease with low-protein diet. J Ren Nutr. 2014;24:313-21.
49. Scalone L, Borghetti F, Brunori G, et al. Cost-benefit analysis of supplemented very low-protein diet versus dialysis in elderly CKD5 patients. Nephrol Dial Transplant. 2010;25:907-13.
50. Giovannetti S. Dietary treatment of chronic renal failure: why is it not used more frequently? Nephron. 1985;40:1-12.
51. Piccoli GB, Deagostini MC, Vigotti FN, et al. Which low-protein diet for which CKD patient? An observational, personalized approach. Nutrition. 2014;30:992-9.
52. Maiorca R, Brunori G, Viola BF, Zubani R, Cancarini G, Parrinello G, De Carli A. Diet or dialysis in the elderly? The DODE study: a prospective randomized multicenter trial. J Nephrol. 2000;13:267-70.
53. Brunori G, Viola BF, Parrinello G, et al. Efficacy and safety of a very-low-protein diet when postponing dialysis in the elderly: a prospective randomized multicenter controlled study. Am J Kidney Dis. 2007;49:569-80.
54. Garneata L, Mircescu G. Effect of low-protein diet supplemented with keto acids on progression of chronic kidney disease. J Ren Nutr. 2013;23:210-3.
55. Teplan V. Effect of keto acids on asymmetric dimethylarginine, muscle, and fat tissue in chronic kidney disease and after kidney transplantation. J Ren Nutr. 2009;19(5 Suppl):S27-9.
56. Teplan V, Schück O, Knotek A, Hajný J, Horácková M, Skibová J. Malý J Effects of low-protein diet supplemented with ketoacids and erythropoietin in chronic renal failure: a long-term metabolic study. Ann Transplant. 2001;6:47-53.
57. Cianciaruso B, Pota A, Pisani A, et al. Metabolic effects of two low protein diets in chronic kidney disease stage 4-5--a randomized controlled trial. Nephrol Dial Transplant. 2008;23:636-44.
58. Bellizzi V, Chiodini P, Cupisti A, et al. Very low-protein diet plus ketoacids in chronic kidney disease and risk of death during end-stage renal disease: a historical cohort controlled study. Nephrol Dial Transplant. 2015;30:71-7.
59. Garneata L, Stancu A, Dragomir D, Stefan G, Mircescu G. Ketoanalogue-Supplemented Vegetarian Very Low-Protein Diet and CKD Progression. J Am Soc Nephrol. 2016. [Epub ahead of print].
60. Giovannetti S, on behalf of the Steering Committee of the European Study Groups for the conservative treatment of chronic renal failure. Answers to ten questions on the dietary treatment of chronic renal failure. Lancet. 1986;328:1140-2.
61. Fouque D, Aparicio M. Eleven reasons to control the protein intake of patients with chronic kidney disease. Nat Clin Pract Nephrol. 2007;3:383-92.
62. Aparicio M, Chauveau P, Combe C. Low protein diets and outcome of renal patients. J Nephrol. 2001;14(6):433-9.
63. Chen LI, Guh JY, Wu KD, Chen YM, Kuo MC, Hwang SJ, Chen TH, Chen HC. Modification of diet in renal disease (MDRD) study and CKD epidemiology collaboration (CKD-EPI) equations for Taiwanese adults. PLoS One. 2014;9:e99645.
64. McCullough ML, Feskanich D, Stampfer MJ, et al. Diet quality and major chronic disease risk in men and women: moving toward improved dietary guidance. Am J Clin Nutr. 2002;76:1261-71.
65. Johnson DW. Dietary protein restriction as a treatment for slowing chronic kidney disease progression: the case against. Nephrology (Carlton). 2006;11:58-62.
66. Maroni BJ. Protein restriction and malnutrition in renal disease: fact or fiction? Miner Electrolyte Metab. 1997;23:225-8.
67. Combe C, Deforges-Lasseur C, Caix J, Pommereau A, Marot D, Aparicio M. Compliance and effects of nutritional treatment on progression and metabolic disorders of chronic renal failure. Nephrol Dial Transplant. 1993;8:412-8.
68. Maroni BJ. Protein restriction in the pre-end-stage renal disease (ESRD) patient: who, when, how, and the effect on subsequent ESRD outcome. J Am Soc Nephrol. 1998;9(12 Suppl):S100-6.
69. Piccoli GB. The never-ending search for the perfect dialysis. Should we move from the best treatment to the best system? Nephrol Dial Transplant. 2011;26:1128-31.
70. The FHN Trial Group. In-center hemodialysis six times per week versus three times per week. N Engl J Med. 2010;363:2287-300.
71. Twardowski ZJ, Misra M. "Daily" Dialysis - Lessons from a randomized, controlled trial. N Engl J Med. 2010;363:2363-4.
72. Milas NC, Nowalk MP, Akpele L, et al. Factors associated with adherence to the dietary protein intervention in the Modification of Diet in Renal Disease Study. J Am Diet Assoc. 1995;95:1295-300.
73. Coyne T, Olson M, Bradham K, Garcon M, Gregory P, Scherch L. Dietary satisfaction correlated with adherence in the Modification of Diet in Renal Disease Study. J Am Diet Assoc. 1995;95:1301-6.
74. Ciarambino T, Castellino P, Paolisso G, et al. Long term effects of low protein diet on depressive symptoms and quality of life in elderly Type 2 diabetic patients. Clin Nephrol. 2012;78:122-8.
75. Sánchez C, Aranda P, Planells E, et al. Influence of low-protein dietetic foods consumption on quality of life and levels of B vitamins and homocysteine in patients with chronic renal failure. Nutr Hosp. 2010;25:238-44.
76. Kanazawa Y, Nakao T, Ohya Y, Shimomitsu T. Association of socio-psychological factors with the effects of low protein diet for the prevention of the progression of chronic renal failure. Intern Med. 2006;45:199-206.
77. Piccoli GB, Vigotti FN, Leone F, et al. Low-protein diets in CKD: how can we achieve them? A narrative, pragmatic review. Clin Kidney J. 2015;8:61-70.
78. Bellizzi V. Low-protein diet or nutritional therapy in chronic kidney disease? Blood Purif. 2013;36:41-6.
79. Chauveau P, Aparicio M. Benefits in nutritional interventions in patients with CKD stage 3-4. J Ren Nutr. 2011;21:20-2.
80. Montemurno E, Cosola C, Dalfino G, et al. What would you like to eat, Mr CKD Microbiota? A Mediterranean Diet, please! Kidney Blood Press Res. 2014;39:114-23.
81. Millward DJ, Jackson AA. Protein/energy ratios of current diets in developed and developing countries compared with a safe protein/energy ratio: implications for recommended protein and amino acid intakes. Public Health Nutr. 2004;7:387-405.
82. Volpi E, Campbell WW, Dwyer JT, et al. Is the optimal level of protein intake for older adults greater than the recommended dietary allowance? J Gerontol A Biol Sci Med Sci. 2013;68:677-81.
83. Keys A, Aravanis C, Buchem FSP, Blackburn H. The diet and all-causes death rate in the Seven Countries Study. Lancet. 1981;2:58-61.
84. Trichopoulou A, Lagiou P. Healthy traditional Mediterranean diet: an expression of culture, history, and lifestyle. Nutr Rev. 1997;55:383-9.
85. Estruch R, Ros E, Salas-Salvadó J, et al. PREDIMED Study Investigators. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med. 2013;368:1279-90.
86. Trichopoulou A, Martínez-González MA, Tong TY, et al. Definitions and potential health benefits of the Mediterranean diet: views from experts around the world. BMC Med. 2014;12:112.
87. Larsson SC, Orsini N. Red meat and processed meat consumption and all-cause mortality: a meta-analysis. Am J Epidemiol. 2014;179:282-9.
88. Jacobson MF, Havas S, McCarter R. Changes in sodium levels in processed and restaurant foods, 2005 to 2011. JAMA Intern Med. 2013;173:1285-91.
89. Sylvetsky AC, Dietz WH. Nutrient-content claims--guidance or cause for confusion? N Engl J Med. 2014;371:195-8.
90. World Health Organization. Evaluation of certain food additives. World Health Organ Tech Rep Ser. 2012;974:1-183.
91. Watson D. Vegan News, No. 1, November 1944.
92. Orlich MJ, Singh PN, Sabaté J, et al. Vegetarian Dietary Patterns and the Risk of Colorectal Cancers. JAMA Intern Med. 2015. doi: 10.1001/jamainternmed.2015.59. [Epub ahead of print].
93. Le LT, Sabaté J. Beyond meatless, the health effects of vegan diets: findings from the Adventist cohorts. Nutrients. 2014;6:2131-47.
94. Gilsing AM, Weijenberg MP, Goldbohm RA, Dagnelie PC, van den Brandt PA, Schouten LJ. The Netherlands Cohort Study − Meat Investigation Cohort; a population-based cohort over-represented with vegetarians, pescetarians and low meat consumers. Nutr J. 2013;12:156.
95. Tonstad S, Butler T, Yan R, Fraser GE. Type of vegetarian diet, body weight, and prevalence of type 2 diabetes. Diabetes Care. 2009;32:791-6.
96. Barsotti G, Morelli E, Cupisti A, Meola M, Dani L, Giovannetti S. A low-nitrogen low-phosphorus Vegan diet for patients with chronic renal failure. Nephron. 1996;74:390-4.
97. Anderson JW, Blake JE, Turner J, Smith BM. Effects of soy protein on renal function and proteinuria in patients with type 2 diabetes. Am J Clin Nutr. 1998;68(6 Suppl):1347S-53.
98. Azadbakht L, Esmaillzadeh A. Soy-protein consumption and kidney-related biomarkers among type 2 diabetics: a crossover, randomized clinical trial. J Ren Nutr. 2009;19(6):479-86. doi:10.1053/j.jrn.2009.06.002.
99. Cupisti A, Ghiadoni L, D'Alessandro C, et al. Soy protein diet improves endothelial dysfunction in renal transplant patients. Nephrol Dial Transplant. 2007;22:229-34.
100. Moe SM, Zidehsarai MP, Chambers MA, et al. Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease. Clin J Am Soc Nephrol. 2011;6:257-64.
101. Soroka N, Silverberg DS, Greemland M, Birk Y, Blum M, Peer G, Iaina A. Comparison of a vegetable-based (soya) and an animal-based low-protein diet in predialysis chronic renal failure patients. Nephron. 1998;79:173-80.
102. Buzio C, Mutti A, Perazzoli F, Alinovi R, Arisi L, Negro A. Protein-induced changes in kidney function depend on the time of administration but not on the dietary source. Nephron. 1990;56:234-40.
103. King AJ, Levey AS. Dietary protein and renal function. J Am Soc Nephrol. 1993;3:1723-37.
104. Chauveau P, Combe C, Fouque D, Aparicio M. Vegetarianism: advantages and drawbacks in patients with chronic kidney diseases. J Ren Nutr. 2013;23:399-405.
105. Zhang J, Liu J, Su J, Tian F. The effects of soy protein on chronic kidney disease: a meta-analysis of randomized controlled trials. Eur J Clin Nutr. 2014;68:987-93.
106. Causso C, Arrieta F, Hernández J, et al. Severe ketoacidosis secondary to starvation in a frutarian patient. Nutr Hosp. 2010;25:1049-52.
107. Sitprija V, Suvanpha R. Low protein diet and chronic renal failure in Buddhist monks. Br Med J (Clin Res Ed). 1983;287(6390):469-71.
108. Krucoff MW, Crater SW, Gallup D, et al. Music, imagery, touch, and prayer as adjuncts to interventional cardiac care: the Monitoring and Actualisation of Noetic Trainings (MANTRA) II randomised study. Lancet. 2005;366(9481):211-7.
109. Black DS, Slavich GM. Mindfulness meditation and the immune system: a systematic review of randomized controlled trials. Ann N Y Acad Sci. 2016. doi:10.1111/nyas.12998 [Epub ahead of print].
110. Craig WJ, Mangels AR, Association AD. Position of the American Dietetic Association: vegetarian diets. J Am Diet Assoc. 2009;109:1266-82.
111. American Dietetic Association; Dietitians of Canada. Position of the American Dietetic Association and Dietitians of Canada: vegetarian diets. Can J Diet Pract Res. 2003;64:62-81.
112. Craig WJ. Nutrition concerns and health effects of vegetarian diets. Nutr Clin Pract. 2010;25:613-20.
113. Piccoli GB, Clari R, Vigotti FN, et al. Vegan-vegetarian diets in pregnancy: danger or panacea? A systematic narrative review. BJOG. 2015;122:623-33.
114. Walser M, Mitch WE, Abras E. Supplements containing amino acids and keto acids in the treatment of chronic uremia. Kidney Int Suppl. 1983;16:S285-9.
115. Aparicio M, Bellizzi V, Chauveau P, et al. Keto acid therapy in predialysis chronic kidney disease patients: final consensus. J Ren Nutr. 2012;22(2 Suppl):S22-4.
116. Liou HH. What can a keto acid/amino acid-supplemented protein-restricted diet do for the "butterfly effect" in chronic kidney disease patients? J Ren Nutr. 2009;19(5 Suppl):S15-8.
117. Shah AP, Kalantar-Zadeh K, Kopple JD. Is There a Role for Ketoacid Supplements in the Management of CKD? Am J Kidney Dis. 2015.
118. Piccoli GB, Attini R, Vasario E, et al. Vegetarian supplemented low-protein diets. A safe option for pregnant CKD patients: report of 12 pregnancies in 11 patients. Nephrol Dial Transplant. 2011;26:196-205.
119. Piccoli GB, Leone F, Attini R, et al. Association of low-protein supplemented diets with fetal growth in pregnant women with CKD. Clin J Am Soc Nephrol. 2014;9:864-73.
120. Piccoli GB, Motta D, Martina G, et al. Low-protein vegetarian diet with alpha-chetoanalogues prior to pre-emptive pancreas-kidney transplantation. Rev Diabet Stud. 2004;1:95-102.
121. Piccoli GB, Guzzo G, Vigotti FN, et al. Tailoring dialysis and resuming low-protein diets may favor chronic dialysis discontinuation: Report on three cases. Hemodial Int. 2014;18(3):590-5.
122. Schefold JC, Zeden JP, Fotopoulou C, et al. Increased indoleamine 2, 3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms. Nephrol Dial Transplant. 2009;24:1901-8.
123. Sallée M, Dou L, Cerini C, Poitevin S, Brunet P, Burtey S. The aryl hydrocarbon receptor-activating effect of uremic toxins from tryptophan metabolism: a new concept to understand cardiovascular complications of chronic kidney disease. Toxins (Basel). 2014;6:934-49.
124. Aparicio M, Cano NJ, Cupisti A, et al. Keto-acid therapy in predialysis chronic kidney disease patients: consensus statements. J Ren Nutr. 2009;19(5 Suppl):S33-5.
125. Willcox DC, Willcox BJ, Todoriki H, Suzuki M. The Okinawan diet: health implications of a low-calorie, nutrient-dense, antioxidant-rich dietary pattern low in glycemic load. J Am Coll Nutr. 2009;28(Suppl):500S-16.
126. Miyagi S, Iwama N, Kawabata T, Hasegawa K. Longevity and diet in Okinawa, Japan: the past, present and future. Asia Pac J Public Health. 2003;15(Suppl):S3-9.
127. Gavrilova NS, Gavrilov LA. Comments on dietary restriction, Okinawa diet and longevity. Gerontology. 2012;58:221-3. discussion 224-6.
128. Willcox BJ, Willcox DC, Todoriki H, et al. Caloric restriction, the traditional Okinawan diet, and healthy aging: the diet of the world's longest-lived people and its potential impact on morbidity and life span. Ann N Y Acad Sci. 2007;1114:434-55.
129. Sotos-Prieto M, Moreno-Franco B, Ordovás JM, León M, Casasnovas JA, Peñalvo JL. Design and development of an instrument to measure overall lifestyle habits for epidemiological research: the Mediterranean Lifestyle (MEDLIFE) index. Public Health Nutr. 2015;18:959-67.
130. Fujita R, Braun KL, Hughes CK. The traditional Hawaiian diet: a review of the literature. Pac Health Dialog. 2004;11:250-9.
131. McKerchar C, Bowers S, Heta C, Signal L, Matoe L. Enhancing Māori food security using traditional kai. Glob Health Promot. 2014 Aug 1. pii: 1757975914543573. [Epub ahead of print].
132. Laird BD, Goncharov AB, Egeland GM, Chan HM. Dietary advice on Inuit traditional food use needs to balance benefits and risks of mercury, selenium, and n3 fatty acids. J Nutr. 2013;143:923-30.
133. Li JR, Hsieh YH. Traditional Chinese food technology and cuisine. Asia Pac J Clin Nutr. 2004;13:147-55.
134. Chen C. Eating patterns-- a prognosis for China. Asia Pac J Clin Nutr. 1995;4 Suppl 1:24-8.
135. Mahadevan M, Blair D, Raines ER. Changing food habits in a South Indian Hindu Brahmin community: a case of transitioning gender roles and family dynamics. Ecol Food Nutr. 2014;53:596-617.
136. Ethan D, Basch CH, Rajan S, Samuel L, Hammond RN. A comparison of the nutritional quality of food products advertised in grocery store circulars of high-versus low-income New York City zip codes. Int J Environ Res Public Health. 2013;11:537-47.
137. D'Alessandro C, Rossi A, Innocenti M, et al. Dietary protein restriction for renal patients: don't forget protein-free foods. J Ren Nutr. 2013;23:367-71.
138. Giovannetti S. Low protein diet in chronic uremia: a historical survey. Contrib Nephrol. 1986;53:1-6.
139. Van Duyn MA. Acceptability of selected low-protein products for use in a potential diet therapy for chronic renal failure. J Am Diet Assoc. 1987;87:909-14.
140. Giordano M, Ciarambino T, Castellino P, Paolisso G. Light and shadows of dietary protein restriction in elderly with chronic kidney disease. Nutrition. 2013;29:1090-3.
141. Thilly N. Low-protein diet in chronic kidney disease: from questions of effectiveness to those of feasibility. Nephrol Dial Transplant. 2013;28:2203-5.
142. Cianciaruso B, Capuano A, D'Amaro E, et al. Dietary compliance to a low protein and phosphate diet in patients with chronic renal failure. Kidney Int Suppl. 1989;27:S173-6.
143. Giordano M, Ciarambino T, Castellino P, et al. Long-term effects of moderate protein diet on renal function and low-grade inflammation in older adults with type 2 diabetes and chronic kidney disease. Nutrition. 2014;30:1045-9.
144. Cupisti A, Morelli E, Meola M, Barsotti M, Barsotti G. Vegetarian diet alternated with conventional low-protein diet for patients with chronic renal failure. J Ren Nutr. 2002;12:32-7.
145. http://www.medicinenet.com/script/main/art.asp?articlekey=33619 (last accessed 5th/04/2015).
146. http://www.cancer.gov/dictionary?cdrid=454747 (last accessed 5th/04/2015).
147. Segen's Medical Dictionary. © 2012 Farlex, Inc.
148. The McGraw-Hill Dictionary of Scientific and Technical Terms. Seventh Edition: Mc Graw-Hill, New York;2012.
149. http://www.nlm.nih.gov/medlineplus/complementaryandalternativemedicine.html (last accessed 5th/04/2015).
150. https://nccih.nih.gov/health/whatiscam (last accessed 5th/04/2015).
151. Moorthi RN, Armstrong CL, Janda K, Ponsler-Sipes K, Asplin JR, Moe SM. The effect of a diet containing 70 % protein from plants on mineral metabolism and musculoskeletal health in chronic kidney disease. Am J Nephrol. 2014;40:582-91.
152. Jones L, Moschonis G, Oliveira A, et al. The influence of early feeding practices on healthy diet variety score among pre-school children in four European birth cohorts. Public Health Nutr. 2014;20:1-11.
153. Di Daniele N, Di Renzo L, Noce A, et al. Effects of Italian Mediterranean organic diet vs. low-protein diet in nephropathic patients according to MTHFR genotypes. J Nephrol. 2014;27:529-36.
154. Kovesdy CP. Traditional and novel dietary interventions for preventing progression of chronic kidney disease. J Ren Nutr. 2013;23:241-5.
155. Willingham F. The dietary management of patients with diabetes and renal disease: challenges and practicalities. J Ren Care. 2012;38 Suppl 1:40-51.
156. Ikizler TA. Protein and energy intake in advanced chronic kidney disease: how much is too much? Semin Dial. 2007;20:5-11.
157. Walser M, Hill S. Can renal replacement be deferred by a supplemented very low protein diet? J Am Soc Nephrol. 1999;10:110-6.
158. Sidorenkov G, Navis G. Safety of ACE inhibitor therapies in patients with chronic kidney disease. Expert Opin Drug Saf. 2014;13:1383-95.
159. Mitch WE. Beneficial responses to modified diets in treating patients with chronic kidney disease. Kidney Int Suppl. 2005;94:S133-5.
160. Friedman AN. New evidence for an old strategy to help delay the need for dialysis. Am J Kidney Dis. 2007;49:563-5.
161. De las Cuevas C. Towards a clarification of terminology in medicine taking behavior: compliance, adherence and concordance are related although different terms with different uses. Curr Clin Pharmacol. 2011;6:74-7.
162. Khair K. Compliance, concordance and adherence: what are we talking about? Haemophilia. 2014;20:601-3.
163. Chakrabarti S. What's in a name? Compliance, adherence and concordance in chronic psychiatric disorders. World J Psychiatry. 2014;4:30-6.
164. Patwardhan B, Ayurveda GCP. Guidelines: Need for freedom from RCT ascendancy in favor of whole system approach. J Ayurveda Integr Med. 2011;22:1-4.
165. Gray JA. The shift to personalised and population medicine. Lancet. 2013;382:200-1.
166. Kitsios GD, Kent DM. Personalised medicine: not just in our genes. BMJ 2012;e2161
167. Basch E. Toward patient-centered drug development in oncology. N Engl J Med. 2013;369:397-400.
168. Lin GA. Patient education: one size does not fit all. JAMA Intern Med. 2013;173:1376.
169. Black N. Why we need observational studies to evaluate the effectiveness of health care. BMJ. 1996;312:1215-8.
170. Benson K, Hartz AJ. A comparison of observational studies and randomized, controlled trials. N Engl J Med. 2000;342:1878-86.
171. Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med. 2000;342:1887-92.
172. Barton S. Which clinical studies provide the best evidence? The best RCT still trumps the best observational study. BMJ. 2000;321:255-6.
173. Verhoef MJ, Lewith G, Ritenbaugh C, Boon H, Fleishman S, Leis A. Complementary and alternative medicine whole systems research: beyond identification of inadequacies of the RCT. Complement Ther Med. 2005;13:206-12.
174. Verhoef MJ, Casebeer AL, Hilsden RJ. Assessing efficacy of complementary medicine: adding qualitative research methods to the "Gold Standard". J Altern Complement Med. 2002;8:275-81.
175. Ritenbaugh C, Verhoef M, Fleishman S, Boon H, Leis A. Whole systems research: a discipline for studying complementary and alternative medicine. Altern Ther Health Med. 2003;9:32-6.
176. Bell IR, Koithan M. Models for the study of whole systems. Integr Cancer Ther. 2006;5:293-307.
177. King M, Nazareth I, Lampe F, et al. Conceptual framework and systematic review of the effects of participants' and professionals' preferences in randomised controlled trials. Health Technol Assess. 2005;9:1-186. iii-iv.
178. Cao HJ, Liu JP, Hu H, Wang NS. Using a partially randomized patient preference study design to evaluate the therapeutic effect of acupuncture and cupping therapy for fibromyalgia: study protocol for a partially randomized controlled trial. Trials. 2014;15:280.
179. Hubacher D, Spector H, Monteith C, Chen PL, Hart C. Rationale and enrollment results for a partially randomized patient preference trial to compare continuation rates of short-acting and long-acting reversible contraception. Contraception. 2015;91:185-92.
180. Leiva-Fernández F, Leiva-Fernández J, Zubeldia-Santoyo F, García-Ruiz A, Prados-Torres D, Barnestein-Fonseca P. Efficacy of two educational interventions about inhalation techniques in patients with chronic obstructive pulmonary disease (COPD). TECEPOC: study protocol for a partially randomized controlled trial (preference trial). Trials. 2012;13:64.
181. Klein S, Cumming GP, Lee AJ, Alexander DA, Bolsover D. Evaluating the effectiveness of a web-based intervention to promote mental wellbeing in women and partners following miscarriage, using a modified patient preference trial design: an external pilot. BJOG. 2012;119:762-7.
182. Halpern SD. Evaluating preference effects in partially unblinded, randomized clinical trials. J Clin Epidemiol. 2003;56:109-15.
183. Mu W, Shang H. Understanding patient values and the manifestations in clinical research with traditional chinese medicine-with practical suggestions for trial design and implementation. Evid Based Complement Alternat Med. 2013;2013:847273.
184. Borradaile KE, Halpern SD, Wyatt HR, et al. Relationship between treatment preference and weight loss in the context of a randomized controlled trial. Obesity (Silver Spring). 2012;20:1218-22.
185. Preference Collaborative Review Group. Patients' preferences within randomised trials: systematic review and patient level meta-analysis. BMJ. 2008;337:a1864.
186. Gemmell I, Dunn G. The statistical pitfalls of the partially randomized preference design in non-blinded trials of psychological interventions. Int J Methods Psychiatr Res. 2011;20:1-9.
187. Charon R. The patient-physician relationship. Narrative medicine: a model for empathy, reflection, profession, and trust. JAMA. 2001;286:1897-902.
188. Charon R. What to do with stories: the sciences of narrative medicine. Can Fam Physician. 2007;53:1265-7.
189. Charon R, Wyer P, Working Group NEBM. Narrative evidence based medicine. Lancet. 2008;371:296-7.
190. Meisel ZF, Karlawish J. Narrative vs evidence-based medicine--and, not or. JAMA. 2011;306:2022-3.
191. Spiegel DM, Brady K. Calcium balance in normal individuals and in patients with chronic kidney disease on low-and high-calcium diets. Kidney Int. 2012;81(11):1116-22.
192. Filipowicz R, Beddhu S. Optimal nutrition for predialysis chronic kidney disease. Adv Chronic Kidney Dis. 2013;20(2):175-80.
193. Cupisti A, Kalantar-Zadeh K. Management of natural and added dietary phosphorus burden in kidney disease. Semin Nephrol. 2013;33:180-90.
194. Sarathy S, Sullivan C, Leon JB, Sehgal AR. Fast food, phosphorus-containing additives, and the renal diet. J Ren Nutr. 2008;18:466-70.
195. D'Alessandro C, Piccoli GB, Cupisti A. The "phosphorus pyramid": a visual tool for dietary phosphate management in dialysis and CKD patients. BMC Nephrol. 2015;16:9.
196. Girelli D, Olivieri O, Stanzial AM, et al. Low platelet glutathione peroxidase activity and serum selenium concentration in patients with chronic renal failure: relations to dialysis treatments, diet and cardiovascular complications. Clin Sci (Lond). 1993;84(6):611-7.
197. Huang X, Sjögren P, Ärnlöv J, et al. Serum fatty acid patterns, insulin sensitivity and the metabolic syndrome in individuals with chronic kidney disease. J Intern Med. 2014;275(1):71-83.
198. Saikumar JH, Kovesdy CP. Bicarbonate Therapy in End-Stage Renal Disease: Current Practice Trends and Implications. Semin Dial. 2015. doi: 10.1111/sdi.12373. [Epub ahead of print].
199. Ciarambino T, Ferrara N, Castellino P, Paolisso G, Coppola L, Giordano M. Effects of a 6-days-a-week low protein diet regimen on depressive symptoms in young-old type 2 diabetic patients. Nutrition. 2011;27(1):46-9.
200. Paes-Barreto JG, Silva MI, Qureshi AR, Bregman R, Cervante VF, Carrero JJ, Avesani CM. Can renal nutrition education improve adherence to a low-protein diet in patients with stages 3 to 5 chronic kidney disease? J Ren Nutr. 2013;23:164-71.
201. Pisani A, Riccio E, Bellizzi V, et al. 6-tips diet: a simplified dietary approach in patients with chronic renal disease. Clin Exp Nephrol: A clinical randomized trial; 2015 [Epub ahead of print].
202. Kalantar-Zadeh K. Patient education for phosphorus management in chronic kidney disease. Patient Prefer Adherence. 2013;7:379-90.
203. Porta N, Bonet C, Cobo E. Discordance between reported intention-to-treat and per protocol analyses. J Clin Epidemiol. 2007;60(7):663-9.
204. Sedgwick P. What is intention to treat analysis? BMJ. 2013;346:f3662.